Cognos Therapeutics vs Denali Therapeutics
Cognos Therapeutics vs Denali Therapeutics, compared side by side on 8 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognos Therapeutics is on 8/100 and Denali Therapeutics on 70/100.
Where each one leads
Cognos Therapeutics
- agent readiness: 50/100 against 39/100
Denali Therapeutics
- our overall score: 70/100 against 8/100
At a glance
| Measure | Cognos Therapeutics | Denali Therapeutics |
|---|---|---|
| What it is | Cognos Therapeutics is developing a novel therapeutic approach for neurodegenerative diseases. | Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, HealthTech, Drug Discovery, Neurotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | Not published | 2015 |
| Headquarters | Tel Aviv, Israel | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cognos Therapeutics | Denali Therapeutics |
|---|---|---|
| Total funding | Not published | $1.0B |
| Latest round | Not published | Royalty Funding |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognos Therapeutics | Denali Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 8/100 | 70/100 |
| Team | Not published | 36/100 |
| Search visibility | 10/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | Not published | 57/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognos Therapeutics | Denali Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Tailwind CSS |
| Analytics | Not detected | Segment |
Cognos Therapeutics vs Denali Therapeutics: common questions
Which is better, Cognos Therapeutics or Denali Therapeutics?
On our 0-100 score Denali Therapeutics rates higher (70/100 against 8/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 8 data points above: read the rows that match what you are buying for.
How do Cognos Therapeutics and Denali Therapeutics compare on the numbers?
Cognos Therapeutics leads on agent readiness (50/100 against 39/100). Denali Therapeutics leads on our overall score (70/100 against 8/100).
Read the full Cognos Therapeutics review and pricing or the Denali Therapeutics review and pricing. You can also browse other Cognos Therapeutics alternatives we track.